Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2016
At a glance
- Drugs Fluvastatin (Primary) ; Pimonidazole
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 20 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Sep 2016.
- 21 Dec 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.